ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2874

CD16+monocytes Are Enriched and Functionally Exacerbated in Driving B Cell Activation Under Systemic Lupus Erythematosus Condition

Huaqun Zhu1, Yin Su2, Fanlei Hu3 and Liling Xu3, 1Department of Rheumatology and Immunology/Clinical Immunology Center, Peking University People's Hospital, Beijing, China, 2Department of Rheumatology and Immunology,Clinical Immunology Center, Peking University People's Hospital, Beijing, China, 3Peking University People's Hospital, Beijing, China

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: B cells, monocytes and pathogenesis, SLE

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

  • Background/Purpose: Systemic lupus erythematosus(SLE) was an autoimmune disease characterized by extensive B cell activation and autoantibody production. Human peripheral monocytes could be categorized into three subsets based on differential expression levels of CD14 and CD16: the classical monocytes (CM, CD14++CD16-), the intermediate monocytes (IM, CD14++CD16+) and the nonclassical monocytes (NCM, CD14+CD16++). NCM and IM were collectively addressed as CD16+monocytes. The three subsets had been described to demonstrate diffierent functions in inflammatory process. However, their effects on B cell response in SLE were not well studied.The aim of this study was to determine the frequencies of these subsets and investigate their possible roles in B cell activation and differentiation under SLE condition.

  • Methods: The frequencies of monocyte subsets in the peripheral blood of healthy donors (HC) and patients with SLE were determined by flow cytometry (FACS). Monocyte subsets were sorted and co-cultured with CD19+ B cells. B cell were co-cultured for different subsets detection by FACS, while the supernatant were collected for IgG, IgA and IgM detection by enzyme-linked immunosorbent assay (ELISA). The function of monocyte subsets on B cell was defined as the ratio of the effects of monocyte subsets co-cultured with B cell versus the effects of B cell cultured alone. 

  • Results: CD16+monocytes were obviously expanded in SLE, while CM were significantly reduced. Compared to HCs, monocyte subsets in patients with SLE demonstrated different phenotypes about HLA-DR, CD163, CD80, CD86, CX3CR1 and CCR5 expression. CD16+monocytes induced CD19+B cells to differentiate into memory B (MB) and plasma B (PB) cells but inhibited the generation of regulatory B (Breg) cell in HC donors. However, both PB response and Breg differentiation induced by CD16+monocytes were exacerbated in patients with SLE. IgG secretion from CD19 positive B cells was increased when cocultured with CD16+monocytes in HCs, which was significantly enhanced when co-cultured with CD16+monocytes in patients with SLE. IgA and IgM responses were differentially regulated by monocyte subsets from SLE and HC, respectively. Compared to CM, CD16+monocytes extensively promoted the expansion of IL-17A- and IL-10- producing B cells, suggesting the preferable role of CD16+monocytes in cytokines secretion from B cells in HCs,. In comparison to HCs, the generation of IL-17A-producing B cells in patients with SLE were significantly elevated in the presence of CD16+monocytes, in which the generation of IL-10 producing B cells were obviously attenuated .

  • Conclusion: CD16+monocytes was enriched and shared different cell-surface marker profiles in SLE. These cells played a predominant role in orchestrating B cell activation and differentiation in SLE.


Disclosure: H. Zhu, None; Y. Su, None; F. Hu, None; L. Xu, None.

To cite this abstract in AMA style:

Zhu H, Su Y, Hu F, Xu L. CD16+monocytes Are Enriched and Functionally Exacerbated in Driving B Cell Activation Under Systemic Lupus Erythematosus Condition [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/cd16monocytes-are-enriched-and-functionally-exacerbated-in-driving-b-cell-activation-under-systemic-lupus-erythematosus-condition/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cd16monocytes-are-enriched-and-functionally-exacerbated-in-driving-b-cell-activation-under-systemic-lupus-erythematosus-condition/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology